4.7 Article

Biorelevant media for transport experiments in the Caco-2 model to evaluate drug absorption in the fasted and the fed state and their usefulness

出版社

ELSEVIER
DOI: 10.1016/j.ejpb.2013.10.017

关键词

Biorelevant media; Fasted state; Fed state; Permeability coefficient; Caco-2; Intestinal absorption

资金

  1. State Scholarships Foundation, Greece
  2. Federal Commission for Scholarships for Foreign Students (ESKAS), Switzerland
  3. Center of Microscopy, University of Basel with TEM

向作者/读者索取更多资源

In this work we developed and characterized transport media that simulate the composition of micellar phase of intestinal fluids in the fasted and, especially, in the fed state and are appropriate for evaluating intestinal drug permeability characteristics using the Caco-2 model (FaSSIF-TMCaco and FeSSIF-TMCaco, respectively). Media composition was based on FaSSIF-V2 and FeSSIF-V2 and recently reported data on total lipid concentrations in the micellar phase of contents of the upper small intestine in the fasted and the fed state and was adapted for cell culture compatibility. Permeation data were evaluated by compartmental kinetic modeling. Permeability coefficients, P, of hydrophilic drugs were not affected by media composition. In contrast, P values of a series of lipophilic compounds measured with FaSSIF-TMCaco, and FeSSIF-TMCaco, and reflecting transport by diffusion were smaller than those obtained with a purely aqueous reference transport medium, aq-TMCaco, following the rank order aq-TMCaco > FaSSIF-TMcaco > FeSSIF-TMCaco. The decline of permeability values was stronger as lipophilicity of the compounds increased. Compared with values estimated using aq-TMCaco., permeability was reduced, depending on the compound, by more than 20- to 100-fold when measured with FeSSIF-TMCaco whereas compound ranking in regard to the permeability characteristics was also affected. The impact of reduced P value on flux through the mucosa, hence on drug absorption, in combination with the drug amount loaded on colloidal particles needs to be taken into consideration in PBPK modeling especially when the food effect is evaluated. (C) 2013 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Oncology

Multigene assays in early breast cancer: Insights from recent phase 3 studies

C. Markopoulos, D. M. Hyams, H. L. Gomez, M. Harries, S. Nakamura, T. Traina, A. Katz

Article Pharmacology & Pharmacy

Exploring impact of supersaturated lipid-based drug delivery systems of celecoxib on in vitro permeation across Permeapad® membrane and in vivo absorption

Alexandra-Roxana Ilie, Brendan T. Griffin, Martin Brandl, Annette Bauer-Brandl, Ann-Christin Jacobsen, Maria Vertzoni, Martin Kuentz, Ruzica Kolakovic, Rene Holm

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2020)

Article Chemistry, Medicinal

Characteristics of Contents of Lower intestine in the 65-74 Years of Age Range Could Impact the Performance of Safe and Efficacious Modified Release Products

Maria Vertzoni, Sarah Sulaiman, Konstantinos Goumas, Elisabeth Kersten, Johanna Anlahr, Uwe Muenster, Christos Reppas

Summary: This study characterized the contents of the distal ileum and proximal colon in older individuals compared to young adults, revealing differences in pH, buffer capacity, fatty acid concentrations, and osmolality. These findings suggest that the performance of certain modified release products may vary between older adults and the typical age group used in drug product studies.

JOURNAL OF PHARMACEUTICAL SCIENCES (2021)

Review Pharmacology & Pharmacy

Oral biopharmaceutics tools: recent progress from partnership through the Pharmaceutical Education and Research with Regulatory Links collaboration

Patrick J. O'Dwyer, Karl J. Box, Jennifer Dressman, Brendan T. Griffin, Laura J. Henze, Chara Litou, Christina Pentafragka, Marina Statelova, Maria Vertzoni, Christos Reppas

Summary: The PEARRL project made significant contributions by optimizing existing biopharmaceutics tools and developing new tools for evaluating oral drug products both during drug development and at the regulatory level. The project successfully simplified the composition of biorelevant media for simulating fed state conditions, proposed strategies for incorporating in vitro data into PBPK modelling, and developed novel biopharmaceutics tools for better understanding drug effects. Through networking opportunities and research collaborations, the project achieved substantial progress in advancing biopharmaceutics tools for drug formulation screening and regulatory support.

JOURNAL OF PHARMACY AND PHARMACOLOGY (2021)

Review Pharmacology & Pharmacy

Current challenges and future perspectives in oral absorption research: An opinion of the UNGAP network

Zahari Vinarov, Bertil Abrahamsson, Per Artursson, Hannah Batchelor, Philippe Berben, Andreas Bernkop-Schnurch, James Butler, Jens Ceulemans, Nigel Davies, Didier Dupont, Goril Eide Flaten, Nikoletta Fotaki, Brendan T. Griffin, Vincent Jannin, Janneke Keemink, Filippos Kesisoglou, Mirko Koziolek, Martin Kuentz, Alan Mackie, Antonio J. Melendez-Martinez, Mark McAllister, Anette Mullertz, Caitriona M. O'Driscoll, Neil Parrott, Jadwiga Paszkowska, Petr Pavek, Christopher J. H. Porter, Christos Reppas, Cordula Stillhart, Kiyohiko Sugano, Elena Toader, Katerina Valentova, Maria Vertzoni, Saskia N. De Wildt, Clive G. Wilson, Patrick Augustijns

Summary: The review article discusses the challenges and gaps in understanding oral drug absorption processes, focusing on specific patient populations, regional differences in the gastrointestinal tract, advanced formulations, and food-drug interactions. Controversies and gaps in current knowledge are identified to pave the way for future research in the field of oral drug absorption.

ADVANCED DRUG DELIVERY REVIEWS (2021)

Review Pharmacology & Pharmacy

Impact of gastrointestinal tract variability on oral drug absorption and pharmacokinetics: An UNGAP review

Zahari Vinarov, Mohammad Abdallah, Jose A. G. Agundez, Karel Allegaert, Abdul W. Basit, Marlies Braeckmans, Jens Ceulemans, Maura Corsetti, Brendan T. Griffin, Michael Grimm, Daniel Keszthelyi, Mirko Koziolek, Christine M. Madla, Christophe Matthys, Laura E. McCoubrey, Amitava Mitra, Christos Reppas, Jef Stappaerts, Nele Steenackers, Natalie L. Trevaskis, Tim Vanuytsel, Maria Vertzoni, Werner Weitschies, Clive Wilson, Patrick Augustijns

Summary: Variability in the absorption of oral drugs can be attributed to differences in physiology, special populations, drug properties, and food-drug interactions. Pharmaceutical formulation approaches have been shown to reduce variability in oral drug exposure, but there are still gaps in understanding the impact of colonic factors, sex differences, and gut-related diseases on drug absorption variability.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2021)

Article Pharmacology & Pharmacy

On the usefulness of four in vitro methods in assessing the intraluminal performance of poorly soluble, ionisable compounds in the fasted state

Patrick J. O'Dwyer, Karl J. Box, Georgios Imanidis, Maria Vertzoni, Christos Reppas

Summary: This study evaluated various in vitro methods for assessing the intraluminal performance of low solubility drugs in the fasted state, finding that the choice of methodology depends on the characteristics of the drug substance. Specifically, for salts of acidic drugs like diclofenac potassium, availability and ease of operation of the apparatus are key factors, while for weakly alkaline substances like ritonavir, dynamic dissolution process simulation and specific information requirements are crucial in method selection. Early in drug development, the use of small-scale systems may be necessary due to limited drug substance quantities available.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2022)

Article Pharmacology & Pharmacy

UNGAP best practice for improving solubility data quality of orally administered drugs

M. Vertzoni, J. Alsenz, P. Augustijns, A. Bauer-Brandl, C. A. S. Bergstrom, J. Brouwers, A. Mullerz, G. Perlovich, C. Saal, K. Sugano, C. Reppas

Summary: The COST UNGAP aims to standardize methods for studying oral drug absorption, emphasizing the importance of solubility data for drug development and regulation, and addressing factors that affect data quality.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2022)

Editorial Material Chemistry, Medicinal

Jennifer Dressman-40 years of Oral Drug Absorption

Bertil Abrahamsson, James Butler, Rodrigo Cristofoletti, Edmund Kostewicz, Christoph Saal, Christos Reppas

JOURNAL OF PHARMACEUTICAL SCIENCES (2022)

Article Chemistry, Medicinal

In Vitro Simulation of the Environment in the Upper Gastrointestinal Lumen After Drug Administration in the Fed State Using the TIM-1 System and Comparison With Luminal Data in Adults

Christina Pentafragka, Irena Tomaszewska, Susann Bellmann, Mans Minekus, Ronald Schilderink, Maria Vertzoni, Mark McAllister, Christos Reppas

Summary: In this study, the environment in TIM-1 luminal compartments was evaluated and compared with data from healthy adults. The results showed that the gastric and duodenal compartments of TIM-1 accurately reflected the luminal conditions in adults, but there was an overestimation of bile acid concentrations. Adjustments in gastric emptying/acid secretion rates and bile acids identities are expected to improve the relevance of luminal conditions in TIM-1 compartments with those in adults.

JOURNAL OF PHARMACEUTICAL SCIENCES (2022)

Article Pathology

Discordance between Immunohistochemistry and Erb-B2 Receptor Tyrosine Kinase 2 mRNA to Determine Human Epidermal Growth Factor Receptor 2 Low Status for Breast Cancer

Keying Xu, Jane Bayani, Elizabeth Mallon, Gregory R. Pond, Tammy Piper, Annette Hasenburg, Christos J. Markopoulos, Luc Dirix, Caroline M. Seynaeve, Cornelis J. H. van de Velde, Daniel W. Rea, John M. S. Bartlett

Summary: Based on quantitative molecular analysis of breast cancers using RNA expression, this study found that the dynamic range of HER2 expression in HER2-low expressing breast cancers exceeds the detection range of current immunohistochemistry methods. It suggests that defining HER2-low cancers based on RNA abundance may better serve treatment decision needs. However, further evaluation through prospective clinical trials is needed to validate the efficacy of RNA abundance in identifying HER2-low cancers and predicting treatment response.

JOURNAL OF MOLECULAR DIAGNOSTICS (2022)

Review Psychology, Clinical

The Role of Attachment Styles on Quality of Life and Distress Among Early-Stage Female Breast Cancer Patients: A Systematic Review

Karveli Spyridoula, Galanis Petros, Mitropoulou Eirini Marina, Karademas Evangelos, Markopoulos Christos

Summary: This review study found that attachment anxiety or avoidance can affect the quality of life and distress of early-stage breast cancer patients. Insecure attachment is related to poorer quality of life and higher levels of distress, while avoidant attachment is more frequent and associated with more negative outcomes. Healthcare providers should investigate modifiable personality traits during the initial diagnosis period to identify patients who are more vulnerable to mental health problems, provide personalized care, and reduce emotional burden.

JOURNAL OF CLINICAL PSYCHOLOGY IN MEDICAL SETTINGS (2023)

Article Pharmacology & Pharmacy

Managing the clinical effects of drug-induced intestinal dysbiosis with a focus to antibiotics: Challenges and opportunities

Lea Gnatzy, George Ismailos, Maria Vertzoni, Christos Reppas

Summary: Intestinal dysbiosis refers to changes in the intestinal microbiota that are associated with the development and worsening of diseases in humans. This review briefly presents the clinical effects of drug-induced intestinal dysbiosis and critically reviews methodologies for managing it based on clinical data. A pharmacokinetically-based approach is proposed for mitigating the impact of antimicrobial therapy on intestinal dysbiosis, but further optimization and confirmation of effectiveness to the general population are needed.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2023)

Meeting Abstract Oncology

Axillary Staging in the Setting of a Preoperative Diagnosis of Ductal Cancer In Situ (DCIS): Results of an International Expert Panel and a Critical Guideline Performance Using Frequentist and Bayesian Analysis

Andreas Karakatsanis, Theodoros Foukakis, Per Karlsson, Eleftherios Mamounas, Anees Chagpar, John Boyages, Isabel Rubio, Bjorn Naume, Davide Mauri, Elsken van der Wall, Chirag Shah, Ava Kwong, Priscilla McAuliffe, Oreste Gentilini, Michail Ignatiadis, Ellen Schlichting, Janez Zgajnar, Francesco Meani, Marios Konstantinos Tasoulis, Pat Whitworth, Walter Weber, Petros Charalampoudis, Bahadir Gulluoglu, Lida Pistioli, Tove Filtenborg Tvedskov, Marjut Leidenius, Bruce Mann, Arjen Witkamp, Lynda Wyld, Rosa di Micco, Christos Markopoulos, Antonios Valachis, Fredrik Warnberg

ANNALS OF SURGICAL ONCOLOGY (2020)

暂无数据